Hosted on MSN1mon
Early-stage trial finds stem cell therapy for retinitis pigmentosa is safe
A team of UC Davis Health researchers has shown that CD34 + stem cells can be safely administered into retinitis pigmentosa (RP) patients' eyes and may offer therapeutic benefits. The phase 1 ...
Hosted on MSN1mon
A new strategy to enhance gene therapy for sickle cell disease
Anne Galy, Ph.D., from Inserm, and co-authors, applied a novel lentivirus-based gene therapy strategy in CD34 + hematopoietic progenitor and stem cells (HSPCs) obtained from cord blood.
Medscape4y
The Effect of Smoking on Clinical Presentation and Expression of TLR-2 and CD34 in Oral Lichen Planus Patients
Pain and clinical scores were calculated for each patient. Image analysis to calculate area percent for TLR-2 and CD34 immuno-expression was performed. Data was tabulated and statistically analyzed.